Gmpriority Pharma Ltd

Gmpriority Pharma Ltd from Colchester UK: a small company with an active status, founded five years ago, employs ten people, and holds £262,918 in assets. It’s a family business with four directors and two owners, operating from a real address. The company regularly imports organic chemicals (for 27 months) and exports miscellaneous food products (for 7 months). Experts in liposomal technology, Gmpriority Pharma markets itself as a leader in Europe, specializing in the encapsulation of nutrients for enhanced bioavailability.

The company’s website details a focus on liposomal technology, offering services like private label manufacturing, contract manufacturing, and research and development. They boast state-of-the-art facilities, including a GMP-certified production cleanroom, and highlight a multidisciplinary team with over 35 years of combined expertise. They even have a Professor Najlah on staff and have won awards for innovation. The website also showcases career opportunities, emphasizing collaboration, innovation, and personal growth.

Financially, Gmpriority Pharma Ltd shows some concerning trends. While average number of employees increased by 60% to 16, cash bank on hand only rose by 75% to £10,000. Creditors remained steady at £1.3 million, but other creditors decreased by 57% to £1,500. Current assets increased by 21% to £260,000, while net assets remained at -£640,000. The company’s small size (meeting two of three conditions for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for agility, but the stagnant equity and increasing debt suggest a need for careful financial management. The lack of an auditor mentioned (likely exempt as a small company) means the figures are unaudited. It seems like they are burning through money.

Registered in England/Wales under the registration number 12323150, with a registered address at CO6 1TW, England, Colchester, Essex, Priors Hall Priors Way, Coggeshall.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.